GALNTs as modifiers of the IGFR pathway and methods of use

Details for Australian Patent Application No. 2005265190 (hide)

Owner Exelixis, Inc.

Inventors Bjerke, Lynn Margaret; Shaw, Kenneth, James; Francis-Lang, Helen; Heuer, Timothy, S.; Friedman, Lori, S.; Parks, Annette, L.

Agent Davies Collison Cave

Pub. Number AU-B-2005265190

PCT Pub. Number WO2006/009928

Priority 60/581,696 21.06.04 US

Filing date 20 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 19 May 2011

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/009928 Priority application(s): WO2006/009928

19 May 2011 Application Accepted

  Published as AU-B-2005265190

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265195-CDK9 as modifier of the IGF pathway and methods of use

2005265187-Method and device for cavity obliteration